Source: The Business Journals: Denver

Silvergate: Massachusetts company acquires and renames Colorado-based pharmaceutical business

CutisPharma Inc. has plans to create a new, unified company called Azurity Pharmaceuticals.

Read full article »
Silvergate's Competitors | Silvergate's News | Silvergate's Financials
Stay up-to-date with the latest news on Silvergate Pharmaceuticals
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Neal I. Muni's photo - President & CEO of Silvergate Pharmaceuticals

President & CEO

Neal I. Muni

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Silvergate Pharmaceuticals